+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Structural Heart Devices Market Size, Share & Trends Analysis Report By Type (Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Mitral Repair, Left Atrial Appendage Closure), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 90 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893187
The global structural heart devices market size is expected to reach USD 12.8 billion by 2030, registering a CAGR of 9.3% from 2023 to 2030. The market is expected to witness exponential growth over the next 8 years due to the rapid increase in cardiovascular conditions and increasing power of healthcare expenditure.

The defects are mostly present at birth, thereby directly affecting the under-5 mortality rate of a country. Therefore, rigorous actions are being undertaken by various government bodies across the globe to increase access to treatment. The Centers for Disease Control and Prevention have a public action plan for efficient management of cardiac conditions.

In addition, other organizations are working on improving the scenario for structural heart disease treatment. For instance, in November 2016, the Cardiovascular Research Foundation (CRF) announced a launch of a journal focusing on the diagnosis and treatment of structural heart defects. It was titled Structural Heart: The Journal of the Heart Team and is expected to be launched in May 2017. This is expected to trigger research & development activities along with capital invested in this field, resulting in technological advancements.

Structural Heart Devices Market Report Highlights

  • Surgical Aortic Valve Replacement (SAVR) dominated the market in 2022, closely followed by Transcatheter Aortic Valve Replacement (TAVR). It can be attributed to the longest presence of the technique in the treatment regimen of aortic stenosis
  • Left Atrial Appendage Closure (LAAC) is anticipated to be one of the fastest-growing segment owing to the minimally invasive nature of the procedure. It also helps in the reduction of risk of stroke, thus is projected to have a higher demand
  • Geographically, North America held the largest structural heart devices market share in 2016 and is expected to maintain its position during the forecast period. A high prevalence of cognitive heart diseases is the key reason for this dominance. Moreover, the mandatory CCHD screening for newborns imposed by the Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) in September 2014 also contributes to the growth in this region
  • Asia Pacific is also expected to witness rapid growth over the forecast period. The improved access and capability for treatments in this region is the key reason for this growth


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Structural Heart Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Structural Heart Devices Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Structural Heart Devices Market: Type Estimates & Trend Analysis
4.1. Structural Heart Devices Market: Key Takeaways
4.2. Structural Heart Devices Market: Type Movement & Market Share Analysis, 2022 & 2030
4.3. SAVR (Surgical Aortic Valve Replacement)
4.3.1. SAVR (Surgical Aortic Valve Replacement) market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. TAVR (Transcatheter Aortic Valve Replacement)
4.4.1. TAVR (Transcatheter Aortic Valve Replacement) market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Mitral Repair (Annuloplasty)
4.5.1. Mitral repair (annuloplasty) market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. LAAC (Left Atrial Appendage Closure)
4.6.1. LAAC (Left Atrial Appendage Closure) market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Structural Heart Devices Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Structural Heart Devices Market by Region: Key Takeaways
5.3. North America
5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.2. Germany
5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.3. France
5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.4. Italy
5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.5. Spain
5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.6. Sweden
5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.7. Norway
5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.4.8. Denmark
5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.2. China
5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.3. India
5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.4. Australia
5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.5. Thailand
5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.5.6. South Korea
5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.2. Mexico
5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.6.3. Argentina
5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. Saudi Arabia
5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.2. South Africa
5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.3. UAE
5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
5.7.4. Kuwait
5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Market Participant Categorization
6.2.1. Medtronic plc
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product benchmarking
6.2.1.4. Strategic initiatives
6.2.2. St. Jude Medical, Inc.
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. Boston Scientific Corporation
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. CardioKinetix
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Comed B.V.
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Edwards Lifesciences Corporation
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. LivaNova PLC
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Abbott Laboratories
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. JenaValve Technology, Inc.
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Biomerics, LLC
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 3 North America structural heart devices market, by region, 2018 - 2030 (USD Million)
Table 4 U.S. structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 5 Canada structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 6 Europe structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 7 Europe structural heart devices market, by region, 2018 - 2030 (USD Million)
Table 8 Germany structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 9 UK structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 10 France structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 11 Italy structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 12 Spain structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 13 Sweden structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 14 Norway structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 15 Denmark structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 16 Asia Pacific structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 17 Asia Pacific structural heart devices market, by region, 2018 - 2030 (USD Million)
Table 18 China structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 19 Japan structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 20 India structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 21 Australia structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 22 Thailand structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 23 South Korea structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 24 Latin America structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 25 Latin America structural heart devices market, by region, 2018 - 2030 (USD Million)
Table 26 Brazil structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 27 Mexico structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 28 Argentina structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 29 Middle East and Africa structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 30 Middle East and Africa structural heart devices market, by region, 2018 - 2030 (USD Million)
Table 31 South Africa structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 33 UAE structural heart devices market, by type, 2018 - 2030 (USD Million)
Table 34 Kuwait structural heart devices market, by type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Structural heart devices: Market outlook
Fig. 9 Structural heart devices: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Structural heart devices market driver impact
Fig. 15 Structural heart devices market restraint impact
Fig. 16 Structural heart devices market strategic initiatives analysis
Fig. 17 Structural heart devices market: Type movement analysis
Fig. 18 Structural heart devices market: Type outlook and key takeaways
Fig. 19 SAVR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 TAVR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Mitral repair market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 LAAC market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Global structural heart devices market: Regional movement analysis
Fig. 24 Global structural heart devices market: Regional outlook and key takeaways
Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Medtronic plc
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • CardioKinetix
  • Comed B.V.
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Abbott Laboratories
  • JenaValve Technology, Inc.
  • Biomerics, LLC

Methodology

Loading
LOADING...

Table Information